{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:49:26Z","timestamp":1773888566991,"version":"3.50.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/beha.2001.0135","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:24:48Z","timestamp":1027682688000},"page":"299-319","source":"Crossref","is-referenced-by-count":27,"title":["Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder"],"prefix":"10.1053","volume":"14","author":[{"given":"Emmanuel J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2001.0135_RF1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1182\/blood.V84.3.676.676","article-title":"Commentary: a new classification for von Willebrand disease","volume":"84","author":"Sadler","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0135_RF3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0037-1615883","article-title":"Structure and function of von Willebrand factor","volume":"82","author":"Ruggeri","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF5","first-page":"1","volume":"3","year":"1995","journal-title":"Haemophilia"},{"key":"10.1053\/beha.2001.0135_RF6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1054\/blre.1999.0116","article-title":"Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease","volume":"13","author":"Favaloro","year":"1999","journal-title":"Blood Reviews"},{"key":"10.1053\/beha.2001.0135_RF7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2257.1998.00115.x","article-title":"Review: laboratory methods for the genetic diagnosis of bleeding disorders","volume":"20","author":"Goodeve","year":"1998","journal-title":"Clinical Laboratory Haematology"},{"key":"10.1053\/beha.2001.0135_RF8","unstructured":"Ginsburg, D, Sadler, J, E, von Willebrand factor (VWF) database, 2000"},{"key":"10.1053\/beha.2001.0135_RF9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0268-960X(91)90032-8","article-title":"Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease","volume":"5","author":"Rodeghiero","year":"1991","journal-title":"Blood Reviews"},{"key":"10.1053\/beha.2001.0135_RF10","first-page":"276","article-title":"Desmopressin: a nontransfusional treatment of haemophilia and von Willebrand disease","volume":"22","author":"Mannucci","year":"1992","journal-title":"Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0037-1614447","article-title":"Post-DDAVP thrombocytopenia in Type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation","volume":"81","author":"Casonato","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/ajcp\/112.5.712","article-title":"Laboratory testing, diagnosis and management of von Willebrand's disease: current practice in Australasia","volume":"112","author":"Favaloro","year":"1999","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/beha.2001.0135_RF13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/00313029700169365","article-title":"Laboratory assays for von Willebrand Factor: relative contribution to the diagnosis of von Willebrand's disease","volume":"29","author":"Favaloro","year":"1997","journal-title":"Pathology"},{"key":"10.1053\/beha.2001.0135_RF14","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1055\/s-0037-1614375","article-title":"Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey","volume":"82","author":"Favaloro","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00001721-200012000-00006","article-title":"Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disease: results from the second Australasian laboratory survey","volume":"11","author":"Favaloro","year":"2000","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1053\/beha.2001.0135_RF16","first-page":"39","article-title":"Review: assessment of haemostatic function: follow up evaluation of abnormal \u2018screening\u2019 coagulation tests and possible outcomes","volume":"15","author":"Favaloro","year":"1994","journal-title":"Australian Journal of Medical Science"},{"key":"10.1053\/beha.2001.0135_RF17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0268-960X(05)80014-1","article-title":"Evaluation of mild bleeding disorders and easy bruising","volume":"8","author":"Sham","year":"1994","journal-title":"Blood Reviews"},{"key":"10.1053\/beha.2001.0135_RF18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00000441-199808000-00002","article-title":"Congenital disorders of platelet function: disorders of signal transduction and secretion","volume":"316","author":"Rao","year":"1988","journal-title":"American Journal of Medical Science"},{"key":"10.1053\/beha.2001.0135_RF19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3109\/00313028509084769","article-title":"Clinching the diagnosis: assessment of hemostatic function","volume":"17","author":"Koutts","year":"1985","journal-title":"Pathology"},{"key":"10.1053\/beha.2001.0135_RF20","first-page":"133","article-title":"Comparative evaluation of 17 commercial APTT reagents","volume":"15","author":"Favaloro","year":"1994","journal-title":"Australian Journal of Medical Science"},{"key":"10.1053\/beha.2001.0135_RF21","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V91.4.1325","article-title":"Screening for von Willebrand disease with a new analyser using high shear stress: a study of 60 cases","volume":"91","author":"Fressinaud","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0135_RF22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1365-2141.1999.01604.x","article-title":"Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates","volume":"106","author":"Fressinaud","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0135_RF23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0037-1614626","article-title":"Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease","volume":"82","author":"Cattaneo","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/s-0037-1613973","article-title":"Comparison of the O'Brien filter test and the PFA-100 platelet analyser in the laboratory diagnosis of von Willebrand's disease","volume":"84","author":"Schlammadinger","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF25","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood.V77.12.2547.2547","article-title":"The bleeding time does not predict surgical bleeding","volume":"77","author":"Lind","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0135_RF26","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1182\/blood.V84.10.3363.3363","article-title":"Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding","volume":"84","author":"Caterina","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0135_RF27","doi-asserted-by":"crossref","unstructured":"Hutton, R, A, Ludlam, C, A, Platelet function testing, 1989","DOI":"10.1136\/jcp.42.8.858"},{"key":"10.1053\/beha.2001.0135_RF28","unstructured":"Frojmovic, M, Biorheology, 1999"},{"key":"10.1053\/beha.2001.0135_RF29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1096-8652(199911)62:3<165::AID-AJH6>3.0.CO;2-C","article-title":"Screening for von Willebrand's disease: use of a novel platelet function analyser (PFA-100\u2122) with high sensitivity to disturbances in von Willebrand factor","volume":"62","author":"Favaloro","year":"1999","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0135_RF30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-0032-1313612","article-title":"Description of an in-vitro platelet function analyser: PFA-100\u2122","volume":"21","author":"Kundu","year":"1995","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0135_RF31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0032-1313613","article-title":"Preliminary data from a field trial of the PFA-100\u2122 system","volume":"21","author":"Mammen","year":"1995","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0135_RF32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/107602969600200404","article-title":"Characterisation of an in-vitro platelet function analyser, PFA-100\u2122","volume":"2","author":"Kundu","year":"1996","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1053\/beha.2001.0135_RF33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00001721-199901000-00004","article-title":"Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis","volume":"10","author":"Harrison","year":"1999","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1053\/beha.2001.0135_RF34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2141.1998.00656.x","article-title":"The platelet function analyser (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children","volume":"101","author":"Carcao","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0135_RF35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-2007-996051","article-title":"Use of the PFA-100 in the assessment of primary, platelet related hemostasis in a pediatric setting","volume":"6","author":"Rand","year":"1998","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0135_RF36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-995840","article-title":"PFA-100 system: a new method for assessment of platelet dysfunction","volume":"2","author":"Mammen","year":"1998","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0135_RF37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-0037-1613974","article-title":"Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center","volume":"84","author":"Ortel","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0049-3848(99)00152-8","article-title":"Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function","volume":"96","author":"Kerenyi","year":"1999","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0135_RF39","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood.V93.11.3578","article-title":"Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system","volume":"93","author":"Di Paola","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0135_RF40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0049-3848(99)00102-4","article-title":"Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion","volume":"96","author":"Cattaneo","year":"1999","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0135_RF41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2516.2001.00487.x","article-title":"Laboratory diagnosis of von Willebrand disorder (VWD) and monitoring of DDAVP therapy: efficacy of the PFA-100\u00ae and VWF:CBA as combined diagnostic strategies","volume":"7","author":"Favaloro","year":"2001","journal-title":"Haemophilia"},{"key":"10.1053\/beha.2001.0135_RF42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2516.2001.00486.x","article-title":"Utility of the PFA-100\u00ae for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations","volume":"7","author":"Favaloro","year":"2001","journal-title":"Haemophilia"},{"key":"10.1053\/beha.2001.0135_RF43","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1016\/S0002-8703(98)70245-5","article-title":"Assessment of platelet function assays","volume":"135","author":"Nicholson","year":"1998","journal-title":"American Heart Journal"},{"key":"10.1053\/beha.2001.0135_RF44","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/00005373-199704000-00023","article-title":"Usefulness of thrombelastography in assessment of trauma patient coagulation","volume":"42","author":"Kraufmann","year":"1997","journal-title":"Journal of Trauma"},{"key":"10.1053\/beha.2001.0135_RF45","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0049-3848(98)00163-7","article-title":"The xylum clot signature analyser: a dynamic flow system that simulates vascular injury","volume":"92","author":"Li","year":"1998","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0135_RF46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0037-1614468","article-title":"A new automated method for von Willebrand factor antigen measurement using latex particles","volume":"81","author":"Veyradier","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1096-8652(200101)66:1<53::AID-AJH1009>3.0.CO;2-I","article-title":"Possibility of false negative VWD, or potential VWD misclassification, using LIA technology and due to presence of rheumatoid factor","volume":"66","author":"Favaloro","year":"2001","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0135_RF48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00001721-199706000-00001","article-title":"Evaluation of a new automated ELISA test for von Willebrand factor using two monoclonal antibodies","volume":"8","author":"Pittet","year":"1997","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1053\/beha.2001.0135_RF49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/ajcp\/104.3.264","article-title":"Laboratory assessment of von Willebrand factor: use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms","volume":"104","author":"Favaloro","year":"1995","journal-title":"American Journal of Clinical Patholology"},{"key":"10.1053\/beha.2001.0135_RF50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0049-3848(98)00078-4","article-title":"von Willebrand factor: measuring its antigen or function? Correlation between the level of antigen, activity, and multimer size using various detection systems","volume":"91","author":"Fischer","year":"1998","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0135_RF51","first-page":"362","article-title":"Ristocetin. A new tool in the investigation of platelet aggregation","volume":"26","author":"Howard","year":"1971","journal-title":"Thrombosis et Diathesis Haemorrhagica"},{"key":"10.1053\/beha.2001.0135_RF52","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1172\/JCI107465","article-title":"Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation","volume":"52","author":"Weiss","year":"1973","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0135_RF53","first-page":"306","article-title":"A method for assaying von Willebrand's factor (ristocetin cofactor)","volume":"34","author":"MacFarlane","year":"1975","journal-title":"Thrombosis et Diathesis Haemorrhagica"},{"key":"10.1053\/beha.2001.0135_RF54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/107602969700300208","article-title":"Laboratory assessment of von Willebrand factor: altered interpretation of laboratory data, and altered diagnosis of von Willebrand's disease, as influenced by the use of different VWF assays and assay conditions","volume":"3","author":"Favaloro","year":"1997","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1053\/beha.2001.0135_RF55","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2141.1985.tb07350.x","article-title":"An immunoradiometric assay for human factor VIII von Willebrand factor (VIII:VWF) using a monoclonal antibody that defines a functional epitope","volume":"59","author":"Goodall","year":"1985","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0135_RF56","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-0038-1661555","article-title":"A two-site, monoclonal antibody based immunoassay for von Willebrand factor\u2014demonstration that VWF function resides in a conformational epitope","volume":"55","author":"Chand","year":"1986","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF57","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1055\/s-0038-1657727","article-title":"von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use","volume":"78","author":"Murdock","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF58","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1055\/s-0037-1615375","article-title":"Assays for von Willebrand factor functional activity: a UK NEQAS Survey","volume":"80","author":"Preston","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0037-1613768","article-title":"Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrands disease (VWD) and discrimination of VWD subtypes depends on collagen source","volume":"83","author":"Favaloro","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF60","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1055\/s-0037-1614064","article-title":"Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of von Willebrand factor: collagen binding activity\/assay (VWF:CBA) with monoclonal antibody (MAB) based ELISA VWF-detection systems","volume":"84","author":"Favaloro","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF61","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1309\/2PMF-3HK9-V8TT-VFUN","article-title":"Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of commercial ELISA-based options used to detect qualitative von Willebrand factor (VWF) defects","volume":"114","author":"Favaloro","year":"2000","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/beha.2001.0135_RF62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0049-3848(86)90150-7","article-title":"An ELISA test for the binding of von Willebrand antigen to collagen","volume":"43","author":"Brown","year":"1986","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0135_RF63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001721-199104000-00011","article-title":"Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between Type I and Type II, von Willebrand's disease","volume":"2","author":"Favaloro","year":"1991","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1053\/beha.2001.0135_RF64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/00313029309084791","article-title":"von Willebrand\u2019s disease: laboratory investigation using an improved functional assay for von Willebrand factor","volume":"25","author":"Favaloro","year":"1993","journal-title":"Pathology"},{"key":"10.1053\/beha.2001.0135_RF65","first-page":"1160","article-title":"Characterisation of plasma-derived and recombinant human VWF by improved collagen binding assays","volume":"73","author":"Siekmann","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-3848(96)00161-2","article-title":"Effect of multimerisation of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII","volume":"84","author":"Fischer","year":"1996","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0135_RF67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-2143(97)90147-5","article-title":"Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers","volume":"129","author":"Casonato","year":"1997","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1053\/beha.2001.0135_RF68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/biol.1998.0127","article-title":"Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay","volume":"26","author":"Ramasamy","year":"1998","journal-title":"Biologicals"},{"key":"10.1053\/beha.2001.0135_RF69","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ajcp\/111.3.418","article-title":"Binding of von Willebrand factor to collagen by flow cytometry","volume":"111","author":"Kempfer","year":"1999","journal-title":"American Journal of Clinical Patholology"},{"key":"10.1053\/beha.2001.0135_RF70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/(SICI)1096-8652(200004)63:4<197::AID-AJH6>3.0.CO;2-2","article-title":"Type 2B von Willebrand's disease in thirteen individuals from five unrelated Australian families: phenotype and genotype correlations","volume":"63","author":"Facey","year":"2000","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0135_RF71","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1055\/s-0038-1660152","article-title":"Multicenter comparison of von Willebrand factor multimer sizing techniques. Report of the FVIII and von Willebrand factor subcommittee","volume":"54","author":"Mannuci","year":"1985","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0135_RF72","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0049-3848(92)90050-K","article-title":"Multimeric analysis of von Willebrand factor by vertical sodium docecyl sulphate agarose gel electrophoresis, vacuum blotting technology and sensitive visualisation by alkaline phosphatase anti-alkaline phosphatase complex","volume":"66","author":"Baillod","year":"1992","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0135_RF73","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII","volume":"74","author":"Nishino","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0135_RF74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ajcp\/109.3.347","article-title":"The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications","volume":"109","author":"Casonato","year":"1998","journal-title":"American Journal of Clinical Patholology"},{"key":"10.1053\/beha.2001.0135_RF75","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V56.4.712.712","article-title":"Serial studies in von Willebrand's disease: variability versus \u2018variants\u2019","volume":"56","author":"Abildgaard","year":"1980","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0135_RF76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajh.2830400208","article-title":"On laboratory problems in diagnosing mild von Willebrand's disease","volume":"40","author":"Blomback","year":"1992","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0135_RF77","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2516.1996.tb00140.x","article-title":"Laboratory assessment of von Willebrand factor: differential influence of prolonged ambient temperature specimen storage on assay results","volume":"2","author":"Favaloro","year":"1996","journal-title":"Haemophilia"},{"key":"10.1053\/beha.2001.0135_RF78","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.2830450303","article-title":"von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy","volume":"45","author":"Favaloro","year":"1994","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0135_RF79","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.88.14.6377","article-title":"Expression of von Willebrand factor \u2018Normandy\u2019: an autosomal mutation that mimics as hemophilia A","volume":"88","author":"Tuley","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0135_RF80","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V78.9.2310.2310","article-title":"The binding of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin and collagen and resides between amino acid residues Leu 512 and Lys 673","volume":"78","author":"Christophe","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0135_RF81","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1016\/S0021-9258(17)35782-4","article-title":"von Willebrand factor binds specifically to sulfated glycolipids","volume":"261","author":"Roberts","year":"1986","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0135_RF82","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0049-3848(99)00232-7","article-title":"Sulfatide-binding assay for von Willebrand factor: detection of von Willebrands disease without discrimination of VWD subtypes","volume":"98","author":"Favaloro","year":"2000","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0135_RF83","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2141.1999.01358.x","article-title":"Identification and characterisation of a novel mutation in von Willebrand Factor causing a Type 2B von Willebrand's disease","volume":"105","author":"Facey","year":"1999","journal-title":"British Journal of Haematology"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T06:26:18Z","timestamp":1621146378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692601901355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1521692601901355"],"URL":"https:\/\/doi.org\/10.1053\/beha.2001.0135","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}